Fresenius SE & Co. KGaA FSNUY OTC

Fresenius SE & Co. KGaA (FSNUY) reported total assets of $41.38B and total liabilities of $21.62B for fiscal year 2025, resulting in total equity of $19.76B.

The company held $1.58B in cash and short-term investments. Total debt stood at $11.93B, with net debt of $10.34B. The Debt-to-Equity (D/E) ratio was 0.6 (moderate).

Current ratio is 1.32, suggesting adequate short-term liquidity. Interest coverage is 5x (adequate).

Criteria supported by this page:

• HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (65/100) — Total assets $41.38B and equity $19.76B support the company's competitive scale
• VALUE (12/100) — Debt-to-Equity 0.6 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 53/100 with 1/7 criteria passed.

RMYHY

Ramsay Health Care Limited

$6.98

+0.00%

MFCSF

Medical Facilities Corporation

$12.23

-1.48%

MCIOF

MCI Onehealth Technologies Inc.

$0.55

-1.10%

NVLPF

Nova Leap Health Corp.

$0.26

+0.00%

AIH

Aesthetic Medical International Holdings Group Limited

$0.33

-33.19%

JNHMF

Jack Nathan Medical Corp.

$0.01

+1,018.75%

LLY

Eli Lilly and Company

$922.50

-0.76%

JNJ

Johnson & Johnson

$240.10

+0.90%